Skip to main content
Premium Trial:

Request an Annual Quote

EliTech SARS-CoV-2, Influenza, RSV Multiplex Test Receives CE Mark

NEW YORK – EliTech Group announced Tuesday its SARS-CoV-2 Plus Elite MGB Kit received CE marking and has been launched.

The kit detects and distinguishes between SARS-CoV-2, influenza A/B, and respiratory syncytial virus types A and B, the company said in a statement. It runs on the firm's Elite InGenius platform, as well as other major PCR thermocyclers. 

In March, the company received Emergency Use Authorization from the US Food and Drug Administration for its GeneFinder COVID-19 Plus RealAmp Kit in partnership with OsangHealthcare. The kit also runs on EliTech's InGenius platform and is authorized for use with nasopharyngeal, oropharyngeal, nasal, and mid-turbinate nasal swab specimens. 

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.